A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1997
12/02/1997	US5693337 Stable lipid emulsion
12/02/1997	US5693336 Contains a phosphatidylcholine, cholesterol and dimyristoylphosphatidylglycerol
12/02/1997	US5693335 Using a mixture of (1) a polyhydric thioalcohol having at least one mercapto and one hydroxy group and (2) a fatty acid or ester; transdermal patches; estrogen therapy
12/02/1997	US5693334 Comprising a gum base, dispersed particles of an alkali metal bicarbonate and a peroxy compound; anticaries agents
12/02/1997	US5693312 Pharmaceutical composition having analgesic activity
12/02/1997	US5693258 Method for improving foaming properties and foaming composition
12/02/1997	US5693255 Oil-in-water type emulsion composition
12/02/1997	US5693034 Lubricous polymer network
12/02/1997	US5693017 Apparatus and method of delivery of gas-supersaturated solutions to a delivery site
12/02/1997	CA2052679C Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
11/1997
11/27/1997	WO1997044074A1 Nutritional support system
11/27/1997	WO1997044070A1 Polysaccharide sponges for cell culture and transplantation
11/27/1997	WO1997044065A2 Device and method for encapsulated gene therapy
11/27/1997	WO1997044062A1 The use of 5-ht1b/1d agonists to treat ocular pain
11/27/1997	WO1997044057A1 System and method for delivery of cytokines using encapsulated cytokine-secreting cells
11/27/1997	WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	WO1997044048A1 Cosmetic compositions
11/27/1997	WO1997044039A1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
11/27/1997	WO1997044032A1 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics
11/27/1997	WO1997044023A1 Pharmaceutical compositions based on diclofenac
11/27/1997	WO1997044022A1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
11/27/1997	WO1997044021A1 Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate
11/27/1997	WO1997044018A1 Dermal compositions comprising acrylate polymers, nicotine and low-swell clay
11/27/1997	WO1997044017A1 Effervescent bisphosphonate formulation
11/27/1997	WO1997044016A1 Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
11/27/1997	WO1997044015A1 Microparticles and their use in wound therapy
11/27/1997	WO1997044014A1 Antifungal compositions with improved bioavailability
11/27/1997	WO1997044013A1 Aerodynamically light particles for pulmonary drug delivery
11/27/1997	WO1997044012A1 Formulation comprising microparticles, for inhalation
11/27/1997	WO1997044011A1 Membrane system for controlled release of a soluble substance
11/27/1997	WO1997043989A1 Compositions, methods and devices for the transdermal delivery of drugs
11/27/1997	WO1997043899A1 Solution and process for resuscitation and reparation of ischemically damaged tissue
11/27/1997	WO1997039739A3 Polyol composition
11/27/1997	WO1997039738A3 Sustained release ionic conjugate
11/27/1997	WO1997032572A3 Materials and methods for enhancing cellular internalization
11/27/1997	CA2256365A1 Compositions, methods and devices for the transdermal delivery of drugs
11/27/1997	CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	CA2253478A1 Formulation comprising microparticles, for inhalation
11/27/1997	CA2252667A1 Device and method for encapsulated gene therapy
11/27/1997	CA2252665A1 System and method for delivery of cytokines using encapsulated cytokine-secreting cells
11/26/1997	EP0809110A1 Macromolecular microparticles and methods of production
11/26/1997	EP0808636A1 Method for partial liquid ventilation using fluorocarbons
11/26/1997	EP0808629A1 Sucralfate preparation
11/26/1997	EP0808174A1 Medicament in particle form
11/26/1997	EP0808170A1 Treatment of diabetic neuropathy
11/26/1997	EP0808161A1 Solid substances comprising valproic acid and sodium valproate
11/26/1997	EP0808158A1 Medicament form for the delivery of active substances to wounds
11/26/1997	EP0808157A1 Medicated tissue paper product
11/26/1997	EP0808156A1 Compositions comprising nanoparticles of nsaid
11/26/1997	EP0808155A1 Sugar base surfactant for nanocrystals
11/26/1997	EP0808154A1 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
11/26/1997	EP0808153A1 Method and device for administering analgesics
11/26/1997	EP0808149A1 Improved topical application emulsions
11/26/1997	EP0773012B1 Means for atomizing mineral water
11/26/1997	EP0705095B1 Combinations of viscoelastics for use during surgery
11/26/1997	EP0686037A4 Hormone replacement therapy
11/26/1997	CN1166136A Prepn. of multivesicular liposomes for controlled release of active agents
11/26/1997	CN1165694A Effective medicine for treating apoplexy
11/26/1997	CN1165686A Medicinal cream for treating sore and its prepn. method
11/26/1997	CN1165684A Oral instant powder for face beauty and its prepn. method
11/26/1997	CN1165682A Method for prepn. of external-use tincture for treating toothache by supply from ear acupoint
11/26/1997	CN1165678A Health products for lowering blood fat, lowering blood sugar and regulating immunity function
11/26/1997	CN1165676A Instant powder for nourishing blood and its prepn. method
11/26/1997	CN1165675A Drug for treating pharyngitis, laryngitis and psora
11/26/1997	CN1165673A Quick effect compounded wet burn and scald prescription
11/26/1997	CN1165671A Method for prepn. of Chinese medicinal cream for treating psoriasis
11/26/1997	CN1165667A Asthma capsules and prepn. method
11/26/1997	CN1165664A Prescription and production of medicine for treatment of gastric ulcer, duodenal ulcer and esophagus ulcer
11/26/1997	CN1165653A Stable aqueous solubilizates of carotenoids and vitamins
11/26/1997	CN1165652A Meadow saffron alkaline pasting agent
11/25/1997	US5691451 Method for sterilizing recombinant human serum albumin pharmaceutical preparation
11/25/1997	US5691343 Crohn*s disease
11/25/1997	US5691060 Biocompatible
11/25/1997	US5690962 Mixing with group 1a compound
11/25/1997	US5690961 Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
11/25/1997	US5690960 Magnesium salt; oral form
11/25/1997	US5690959 Pharmaceutical thermal infusion process
11/25/1997	US5690957 Prostaglandin derivatives
11/25/1997	US5690956 Hair care perming agent
11/25/1997	US5690955 Wound dressing
11/25/1997	US5690954 Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
11/25/1997	US5690952 Implantable system for delivery of fluid-sensitive agents to animals
11/25/1997	US5690923 Stable topical retinoid compositions
11/25/1997	US5690910 Administering heparins
11/25/1997	US5690869 Use of a polymer material on the basis of modified hydrocolloids as covering material
11/22/1997	CA2206000A1 Tissue/cleaning system for improved hygiene
11/20/1997	WO1997043363A1 Cationic lipids and methods of use therefor
11/20/1997	WO1997043005A1 Targeted hysteresis hyperthermia as a method for treating diseased tissue
11/20/1997	WO1997042987A1 Composition and method for forming biodegradable implants in situ and uses of these implants
11/20/1997	WO1997042979A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	WO1997042975A2 Chitosan related compositions for delivery of nucleic acids into a cell
11/20/1997	WO1997042968A2 Administration of histamine for therapeutic purposes
11/20/1997	WO1997042963A2 Green ointment
11/20/1997	WO1997042962A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/20/1997	WO1997042959A1 Emergency contraceptive kit
11/20/1997	WO1997042952A1 Percutaneous tape preparation containing fentanyl
11/20/1997	WO1997042941A2 Buccal delivery system
11/20/1997	WO1997042940A1 Method for fabricating polymer-based controlled-release devices
11/20/1997	WO1997042939A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity
11/20/1997	WO1997042938A1 Delivery of biologically active material in a liposomal formulation for administration into the mouth

1 ... 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 ... 2991